Treatment persistence and maintenance dose titration among ulcerative colitis patients on biologics: A pooled study of three United States claims databases

Abstract Objective: This real-world study evaluated biologic treatment patterns in moderate-to-severe ulcerative colitis (UC) patients. Methods: IQVIA® PharMetrics®, IBM® MarketScan®, and Optum Clinformatics™ were pooled to identify UC patients with ≥1 claim for UC...